Ant has awarded Menarini the Eubiosia prize for the excellence of the Mimosa Study.

The aim of the Mimosa Study is to single out a vaccine against ovarian cancer, a rare disease which nevertheless has a high mortality rate.

Yesterday, 19th November 2009, the President and the Secretary General of the ANT association awarded Menarini with the prize belonging to the "Innovation within a common scientific project" category.

"We are honoured to receive this acknowledgement from ANT as we have been able to get first hand experience of the commitment and dedication of the foundation which is devoted to helping cancer sufferers" commented Dr. Angela Capriati, Director of Clinical Research for the Menarini Group.

www.mimosa-study.com
www.menarini.com
www.antitalia.org